WallStreetZenWallStreetZen

NASDAQ: ALLR
Allarity Therapeutics Inc Stock Ownership - Who owns Allarity Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Allarity Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jeremy R. GraffPresident and Chief Development Officer2025-09-3014,613$1.58
$23.09kSell

1 of 1

ALLR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALLR insiders and whales buy or sell their stock.

ALLR Shareholders

What type of owners hold Allarity Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Leon Sass6.87%1,086,238$1.11MInsider
Thomas Jensen2.51%396,734$404.67kInsider
Jeremy R. Graff2.41%381,644$389.28kInsider
Renaissance Technologies LLC1.57%247,612$252.56kInstitution
Vanguard Group Inc1.56%246,708$251.64kInstitution
Geode Capital Management LLC0.99%156,640$159.77kInstitution
State Street Corp0.87%137,600$140.35kInstitution
Steen Knudsen0.79%124,976$127.48kInsider
Drw Securities LLC0.78%122,741$125.20kInstitution
Capital Advisors Inc0.63%100,000$102.00kInstitution

1 of 3

ALLR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALLR8.17%13.31%Net Selling
VYNE24.02%75.98%Net SellingNet Selling
INTS64.96%35.04%Net BuyingNet Buying
QCLS9.32%90.68%
CTXR7.69%2.52%
View Top Biotech Stocks

Allarity Therapeutics Stock Ownership FAQ

Who owns Allarity Therapeutics?

Allarity Therapeutics (NASDAQ: ALLR) is owned by 8.17% institutional shareholders, 13.31% Allarity Therapeutics insiders, and 78.52% retail investors. Leon Sass is the largest individual Allarity Therapeutics shareholder, owning 1.09M shares representing 6.87% of the company. Leon Sass's Allarity Therapeutics shares are currently valued at $1.35M.

If you're new to stock investing, here's how to buy Allarity Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.